{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:16:46Z","timestamp":1792124206731,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Eastern Finland (UEF) including Kuopio University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neonatal hyperbilirubinemia is observed in most newborns, and 5\u201315% of neonates require phototherapy. Phototherapy is effective but often prolongs hospitalization and has both short-term and potential long-term harms. The aim of this systematic review and meta-analysis was to evaluate the role of ursodeoxycholic acid (UDCA) combined with phototherapy in neonatal hyperbilirubinemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A literature search was conducted on September 1, 2021; 590 studies were screened, and 17 full texts were assessed by two authors. We included randomized controlled trials with or without placebo intervention. Primary outcomes were changes in total bilirubin levels at 24\u00a0hours and phototherapy duration. We calculated mean differences with 95% confidence intervals (CI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Six studies with 880 neonates were included. Of these studies, only two used a placebo-controlled double-blinded design. The overall risk of bias was high in one and moderate in four of the included studies. The mean decrease in the total bilirubin level during the first 24\u00a0hours was 2.06\u00a0mg\/dL (95% CI 0.82\u20133.30; six studies) greater in the UDCA treatment group. The phototherapy duration was 19.7\u00a0hours (95% CI 10.4\u201329.1; five studies) shorter in the UDCA treatment group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found low-quality evidence that UDCA as an adjuvant to phototherapy seems to decrease total bilirubin faster and shorten phototherapy duration compared to standard treatment. Further studies are needed to confirm the efficacy, acute and long-term outcomes, and safety before implementing UDCA as an adjuvant to phototherapy in neonatal hyperbilirubinemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12519-022-00563-z","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T14:02:46Z","timestamp":1654956166000},"page":"589-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-9610","authenticated-orcid":false,"given":"Ilari","family":"Kuitunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panu","family":"Kiviranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Sankilampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo","family":"Renko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"563_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.12968\/hmed.2017.78.12.699","volume":"78","author":"S Mitra","year":"2017","unstructured":"Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med. 2017;78:699\u2013704.","journal-title":"Br J Hosp Med"},{"key":"563_CR2","first-page":"0319","volume":"2015","author":"P Woodgate","year":"2015","unstructured":"Woodgate P, Jardine LA. Neonatal jaundice: phototherapy. BMJ Clin Evid. 2015;2015:0319.","journal-title":"BMJ Clin Evid"},{"key":"563_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1542\/peds.2008-2980","volume":"124","author":"MW Kuzniewicz","year":"2009","unstructured":"Kuzniewicz MW, Escobar GJ, Newman TB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics. 2009;124:1031\u20139.","journal-title":"Pediatrics"},{"key":"563_CR4","doi-asserted-by":"publisher","first-page":"e20160687","DOI":"10.1542\/peds.2016-0687","volume":"138","author":"TB Newman","year":"2016","unstructured":"Newman TB, Wickremasinghe AC, Walsh EM, Grimes BA, McCulloch CE, Kuzniewicz MW. Phototherapy and risk of type 1 diabetes. Pediatrics. 2016;138:e20160687.","journal-title":"Pediatrics"},{"key":"563_CR5","unstructured":"National Institute for Health and Care Excellence. Jaundice in newborn babies under 28 days. 2010. https:\/\/www.nice.org.uk\/guidance\/cg98. Accessed 25 Oct 2021."},{"key":"563_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297\u2013316.","journal-title":"Pediatrics"},{"key":"563_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(58)91849-X","volume":"1","author":"R Cremer","year":"1958","unstructured":"Cremer R, Perryman PW, Richards DH. Influence of light on the hyperbilirubinaemia of infants. Lancet. 1958;1:1094\u20137.","journal-title":"Lancet"},{"key":"563_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/ped.13332","volume":"59","author":"S Itoh","year":"2017","unstructured":"Itoh S, Okada H, Kuboi T, Kusaka T. Phototherapy for neonatal hyperbilirubinemia. Pediatr Int. 2017;59:959\u201366.","journal-title":"Pediatr Int"},{"key":"563_CR9","first-page":"CD007969","volume":"2011","author":"P Kumar","year":"2011","unstructured":"Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev. 2011;2011:CD007969.","journal-title":"Cochrane Database Syst Rev"},{"key":"563_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1056\/NEJMct0708376","volume":"358","author":"MJ Maisels","year":"2008","unstructured":"Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358:920\u20138.","journal-title":"N Engl J Med"},{"issue":"5 Suppl","key":"563_CR11","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/ANC.0b013e31822ee62c","volume":"11","author":"LA Stokowski","year":"2011","unstructured":"Stokowski LA. Fundamentals of phototherapy for neonatal jaundice. Adv Neonatal Care. 2011;11(5 Suppl):S10\u201321.","journal-title":"Adv Neonatal Care"},{"key":"563_CR12","doi-asserted-by":"publisher","first-page":"e20151353","DOI":"10.1542\/peds.2015-1353","volume":"137","author":"AC Wickremasinghe","year":"2016","unstructured":"Wickremasinghe AC, Kuzniewicz MW, Grimes BA, McCulloch CE, Newman TB. Neonatal phototherapy and infantile cancer. Pediatrics. 2016;137:e20151353.","journal-title":"Pediatrics"},{"key":"563_CR13","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/ijc.32158","volume":"145","author":"N Auger","year":"2019","unstructured":"Auger N, Laverdi\u00e8re C, Ayoub A, Lo E, Luu TM. Neonatal phototherapy and future risk of childhood cancer. Int J Cancer. 2019;145:2061\u20139.","journal-title":"Int J Cancer"},{"key":"563_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/bjd.12335","volume":"169","author":"J Ol\u00e1h","year":"2013","unstructured":"Ol\u00e1h J, T\u00f3th-Moln\u00e1r E, Kem\u00e9ny L, Csoma Z. Long-term hazards of neonatal blue-light phototherapy. Br J Dermatol. 2013;169:243\u20139.","journal-title":"Br J Dermatol"},{"key":"563_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eplepsyres.2016.05.004","volume":"124","author":"RD Maimburg","year":"2016","unstructured":"Maimburg RD, Olsen J, Sun Y. Neonatal hyperbilirubinemia and the risk of febrile seizures and childhood epilepsy. Epilepsy Res. 2016;124:67\u201372.","journal-title":"Epilepsy Res"},{"key":"563_CR16","doi-asserted-by":"publisher","first-page":"e20180648","DOI":"10.1542\/peds.2018-0648","volume":"142","author":"TB Newman","year":"2018","unstructured":"Newman TB, Wu YW, Kuzniewicz MW, Grimes BA, McCulloch CE. Childhood seizures after phototherapy. Pediatrics. 2018;142:e20180648.","journal-title":"Pediatrics"},{"key":"563_CR17","first-page":"402","volume":"3","author":"AM Hassan","year":"2015","unstructured":"Hassan AM, Abdulrahman A, Husain RA. Effect of ursodeoxycholic acid in lowering neonatal indirect hyperbilirubinemia: a randomized controlled trial. Merit Res J Med Medical Sci. 2015;3:402\u20135.","journal-title":"Merit Res J Med Medical Sci"},{"key":"563_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MPG.0000000000000874","volume":"62","author":"N Honar","year":"2016","unstructured":"Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S, et al. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. J Pediatr Gastroenterol Nutr. 2016;62:97\u2013100.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"563_CR19","first-page":"99","volume":"5","author":"I Shahramian","year":"2019","unstructured":"Shahramian I, Tabrizian K, Ostadrahimi P, Afshari M, Soleymanifar M, Bazi A. Therapeutic effects of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a randomized double-blind clinical trial. Arch Anesth Crit Care. 2019;5:99\u2013103.","journal-title":"Arch Anesth Crit Care"},{"key":"563_CR20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4103\/mmj.mmj_885_17","volume":"32","author":"FM El-Gendy","year":"2019","unstructured":"El-Gendy FM, Bahbaha WA, Al Kaforyb EE. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. Menoufia Med J. 2019;32:1059\u201363.","journal-title":"Menoufia Med J"},{"key":"563_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.24953\/turkjped.2020.03.009","volume":"62","author":"MM Gharehbaghi","year":"2020","unstructured":"Gharehbaghi MM, Sani AM, Refeey M. Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice. Turk J Pediatr. 2020;62:424\u201330.","journal-title":"Turk J Pediatr"},{"key":"563_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1846705","author":"R Akefi","year":"2020","unstructured":"Akefi R, Hashemi SM, Alinejad S, Almasi-Hashiani A. The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial. J Matern Fetal Neonatal Med. 2020. https:\/\/doi.org\/10.1080\/14767058.2020.1846705.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"563_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CEG.S207523","volume":"12","author":"MD Ughasoro","year":"2019","unstructured":"Ughasoro MD, Adimorah GN, Chukwudi NK, Nnakenyi ID, Iloh KK, Udemba CE. Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy. Clin Exp Gastroenterol. 2019;12:349\u201354.","journal-title":"Clin Exp Gastroenterol"},{"key":"563_CR24","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/jpc.15411","volume":"57","author":"M Rezaie","year":"2021","unstructured":"Rezaie M, Gholami R, Jafari M, Haghighinejad H. Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia. J Paediatr Child Health. 2021;57:1175\u201381.","journal-title":"J Paediatr Child Health"},{"key":"563_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2468-1253(21)00074-1","volume":"6","author":"C Ovadia","year":"2021","unstructured":"Ovadia C, Sajous J, Seed PT, Patel K, Williamson NJ, Attilakos G, et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:547\u201358.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"563_CR26","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1038\/s41598-021-90687-5","volume":"11","author":"LWE van der Schoor","year":"2021","unstructured":"van der Schoor LWE, Verkade HJ, Bertolini A, de Wit S, Mennillo E, Rettenmeier E, et al. Potential of therapeutic bile acids in the treatment of neonatal hyperbilirubinemia. Sci Rep. 2021;11:11107.","journal-title":"Sci Rep"},{"key":"563_CR27","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1542\/peds.2008-0986","volume":"122","author":"S Willot","year":"2008","unstructured":"Willot S, Uhlen S, Michaud L, Briand G, Bonnevalle M, Sfeir R, et al. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics. 2008;122:e1236\u201341.","journal-title":"Pediatrics"},{"key":"563_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/hep.510250303","volume":"25","author":"E Jacquemin","year":"1997","unstructured":"Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 1997;25:519\u201323.","journal-title":"Hepatology"},{"key":"563_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1053\/gast.1996.v111.pm8780577","volume":"111","author":"MI Spagnuolo","year":"1996","unstructured":"Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterol. 1996;111:716\u20139.","journal-title":"Gastroenterol"},{"key":"563_CR30","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"563_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias visualization (robvis): an r package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55\u201361.","journal-title":"Res Synth Methods"},{"key":"563_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"563_CR33","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane. 2021. Accessed Oct 2021. https:\/\/training.cochrane.org\/handbook. Accessed 25 Oct 2021."},{"issue":"21","key":"563_CR34","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"563_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/bfm.2020.0293","volume":"16","author":"YW Chiu","year":"2021","unstructured":"Chiu YW, Cheng SW, Yang CY, Weng YH. Breastfeeding in relation to neonatal jaundice in the first week after birth: parents\u2019 perceptions and clinical measurements. Breastfeed Med. 2021;16:292\u20139.","journal-title":"Breastfeed Med"},{"key":"563_CR36","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1542\/hpeds.2020-0056","volume":"10","author":"K Kovaric","year":"2020","unstructured":"Kovaric K, Cowperthwaite M, McDaniel CE, Thompson G. Supporting breastfeeding in infants hospitalized for jaundice. Hosp Pediatr. 2020;10:502\u20138.","journal-title":"Hosp Pediatr"},{"key":"563_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1010539515624964","volume":"28","author":"C Binns","year":"2016","unstructured":"Binns C, Lee M, Low WY. The long-term public health benefits of breastfeeding. Asia Pac J Public Health. 2016;28:7\u201314.","journal-title":"Asia Pac J Public Health"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00563-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-022-00563-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00563-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T16:08:39Z","timestamp":1660493319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-022-00563-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1007\/s12519-022-00563-z","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethics statement is not applicable because this study is based exclusively on published literature. According to Finnish research legislation, systematic reviews do not require study approval, and therefore, it was not obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}